A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease

Archives of Internal Medicine

Volumn 161, Issue 3, 2001, Pages 411-420

  Breitbart, William ^a   Rosenfeld, Barry ^b   Kaim, Monique ^a   Funesti Esch, Julie ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b FORDHAM UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; PEMOLINE MAGNESIUM; PSYCHOSTIMULANT AGENT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DISTRESS SYNDROME; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED DISEASE; FATIGUE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0035847581     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.3.411     Document Type: Article

References (40)

1. Fatigue in ambulatory AIDS patients
2. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection
3. Signs and symptoms of "asymptomatic" HIV-1 infection in homosexual men
4. Identifying major concerns of persons with acquired immunodefiency syndrome: A replication
5. Comparison of clinical manifestations of HIV infection between male and female injecting drug users
6. Recombinant human erythropoietin and health-related quality of life of AIDS patients with anemia
7. Gastrointestinal manifestations of the acquired immunodeficiency syndrome
8. Current approach to the treatment of human immunodeficiency virus-associated weight loss: Pathophysiologic considerations and emerging management strategies
9. Testosterone replacement therapy in HIV patients
10. Fatigue and myalgia in AIDS patients
11. Fatigue in cancer patients
12. Fatigue mechanisms in cancer patients: Developing nursing theory
13. Fatigue and the cancer experience: The state of knowledge
14. Progress toward guidelines for the managment of fatigue
15. Amelioration of fatigue with pemoline in patients with multiple sclerosis
16. Methylphenidate associated with narcotics for the treatment of cancer pain
17. Asthenia in patients with advanced cancer
18. Fatigue: Current bases for practice
19. A double-blind, randomized crossover trial of pemoline in fatigue associated with multiple sclerosis
20. "Mini-Mental State": A practical method of grading the cognitive state of patients for the clinician
21. The Structured Clinical Interview for DSM-III-R (SCID), I: History, rationale, and description
22. Clinical neuropsychology
23. The development of an instrument to measure the subjective dimension of fatigue
24. Validity and reliability of a scale to assess fatigue
25. Muscle fatigue in some neurological disorders
26. Karnofsky Performance Status revisited: Reliability, validity, and guidelines
27. An inventory for measuring depression
28. The Brief Symptom Inventory: An introductory report
29. The MOS 36-item short-form health survey (SF-36), I: Conceptual framework and item selection
30. General versus systematic inquiry about emergent clinical events with SAFTEE: Implications for clinical research
31. Extra-pyramidal symptom rating scale
32. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults
33. FDA weighs communicating drug-related risk to patients
34. Psychostimulant response in AIDS-related complex patients
35. Methylphenidate for depressive disorders in cancer patients: An alternative to standard antidepressants
36. The clinical and psychological effects of pemoline in depressed patients: A controlled study